Search Results - "Egmond, S. van"

Needs and preferences of patients regarding basal cell carcinoma and cutaneous squamous cell carcinoma care: a qualitative focus group study by Egmond, S., Wakkee, M., Droger, M., Bastiaens, M.T., Rengen, A., Roos, K.P., Nijsten, T., Lugtenberg, M.

“…Summary Background Despite the high and rising incidence rate of keratinocyte cancer (KC) and the importance of incorporating patient values into…”
Get full text

Telehealth for older adults with skin disease: a qualitative exploration of dermatologists’ experiences and recommendations for improving care by Vere Hunt, I., Egmond, S., Nava, V., Khodosh, R., Lester, J., Chiou, A.S., Linos, E.

Get full text

Insight into the management of actinic keratosis: a qualitative interview study among general practitioners and dermatologists by Noels, E.C., Lugtenberg, M., Egmond, S., Droger, S.M., Buis, P.A.J., Nijsten, T., Wakkee, M.

“…Summary Background The increasing incidence of actinic keratosis (AK) is causing a large burden on healthcare systems. The current management of patients with…”
Get full text

Healthcare utilization and management of actinic keratosis in primary and secondary care: a complementary database analysis by Noels, E. C., Hollestein, L. M., Egmond, S., Lugtenberg, M., Nistelrooij, L. P. J., Bindels, P. J. E., Lei, J., Stern, R. S., Nijsten, T., Wakkee, M.

“…Summary Background The high prevalence of actinic keratosis (AK) requires the optimal use of healthcare resources. Objectives To gain insight in to the…”
Get full text

Factors influencing current low‐value follow‐up care after basal cell carcinoma and suggested strategies for de‐adoption: a qualitative study by Egmond, S., Wakkee, M., Rengen, A., Bastiaens, M.T., Nijsten, T., Lugtenberg, M.

“…Summary Background Providing follow‐up to patients with low‐risk basal cell carcinoma (BCC) can be considered as low‐value care. However, dermatologists still…”
Get full text

Tbet-positive regulatory T cells accumulate in oropharyngeal cancers with ongoing tumor-specific type 1 T cell responses by Santegoets, S J, Duurland, C L, Jordanova, E S, van Ham, J J, Ehsan, I, van Egmond, S L, Welters, M J P, van der Burg, S H

“…Regulatory T cells (Tregs) may comprise different subsets allowing them to efficiently suppress different types of effector T cells. In this study, we show…”
Get full text

Men with Kennedy disease have a reduced risk of androgenetic alopecia by Sinclair, R., Greenland, K.J., Egmond, S. van, Hoedemaker, C., Chapman, A., Zajac, J.D.

“…Summary Background  Spinal and bulbar muscular atrophy or Kennedy disease (KD) is an X‐linked neurodegenerative disease caused by an expansion of a polymorphic…”
Get full text

Secondary cancer prevention among the youth: research status and policy recommendations for the EU by Mayer, A, Kosir, U, Feliu Josna, A, Stojanovska, M, Mehmetbeyli, L, van Egmond, S, Miotto, E, Rotberga, L, Margaryan, Y, Chierigo, F

“…Background In early 2021, Europe's Beating Cancer Plan was announced on World Cancer Day. While the European Commission's plan does not include a focus on…”
Get full text

Opportunities for improving the efficiency of keratinocyte carcinoma care in primary and specialist care: Results from population-based Dutch cohort studies by Wakkee, M., van Egmond, S., Louwman, M., Bindels, P., van der Lei, J., Nijsten, T., Hollestein, L.

“…High incidence rates of keratinocyte carcinoma (KC) in Western countries put pressure on healthcare systems. The aim of this study was to describe clinical…”
Get full text

Evolution and Utility of Antiplatelet Autoantibody Testing in Patients with Immune Thrombocytopenia by Porcelijn, Leendert, Schmidt, David E, Oldert, Gonda, Hofstede-van Egmond, Suzanne, Kapur, Rick, Zwaginga, Jaap Jan, de Haas, Masja

“…To this day, immune thrombocytopenia (ITP) remains a clinical diagnosis made by exclusion of other causes for thrombocytopenia. Reliable detection of platelet…”
Get full text

COVID-19 Incidence and Disease Course Among Patients at an Allergy Department by van der Aa, Louise E., van Egmond, Inge S., van der Sluijs, Martijn, den Otter, A.A. Sophie, Bosmans, Nadie H.M., van Beek, Sabine E., Hartman, Angela, Guchelaar, Niels A.D., van Daele, Paul L.A., van Maaren, Maurits S., van Hagen, P. Martin, Hermans, Maud A.W., Rombach, Saskia M.

“…Background Since the coronavirus pandemic in 2020, there is not much reported about the disease course of COVID-19 in patients with allergic diseases…”
Get full text

Flucloxacillin instantly decreases serum levels of valproic acid: A case report by Meer, Douwe H., Elting, Lisa J., Egmond, Pleun S.

“…Valproic acid (VPA) is used for epilepsy and bipolar disorder. It has near‐complete bioavailability and is primarily metabolized by glucuronosyltransferases…”
Get full text

What are the most important factors in basal cell carcinoma follow‐up care? The perspective of patients by van Egmond, S., Lugtenberg, M., Noels, E. C., Wakkee, M., Hollestein, L. M.

Get full text

光化性角化病的管理:全科医生和皮肤科医生的定性访谈研究 by Noels, E.C., Lugtenberg, M., van Egmond, S., Droger, S.M., Buis, P.A.J., Nijsten, T., Wakkee, M.

“…Summary 光化性角化病 (AK) 是浅色皮肤的人因为长期暴露在阳光下而引起的粗糙的皮肤损伤(斑块),它影响 24‐60% 的 50 岁以上人群。目前对 AK…”
Get full text

Comparison of two treatments for verapamil overdose by Eijsink, Job F. H., Grol, Baue J. H., Naber, Harry R., van Egmond, Pleun S.

Get full text

Pharmacokinetics of golimumab in moderate to severe ulcerative colitis: the GO-KINETIC study by Berends, Sophie E., Strik, Anne S., Jansen, Jeroen M., de Boer, Nanne K., van Egmond, Pleun S., Brandse, Johannan F., Mathôt, Ron A., D'Haens, Geert R., Löwenberg, Mark

“…Background: Golimumab (GLM) is approved for the treatment of moderate to severe ulcerative colitis (UC). Higher serum concentrations of anti-tumor necrosis…”
Get full text

Increasing lithium concentration despite extracorporeal treatment: a case report by Smolders, Elise J., van Egmond, Pleun S., Doornebal, Joan, Naber, Harry, ter Horst, Peter G. J., Diepeveen, Sabine H. A.

“…Lithium is used for the treatment of bipolar disorders; however, as lithium is renally excreted, it accumulates, with loss of renal function. We describe a…”
Get full text

384 Impact of the COVID-19 pandemic on dermatology visits among older adults and racial and ethnic minorities by Rizk, N., Mathur, M.B., Ko, J., Chiou, A., de Vere Hunt, I., van Egmond, S., Linos, E.

Get full text

P07 The tumor immune microenvironment and its association with progression free survival in patients with oropharyngeal squamous cell carcinoma by Bruijnes, N., Straver, O., Oomen, L., Bos, T., Hondelink, L., van Egmond, S., Slingerland, M., Cohen, D.

Get full text

374 529 dermatologists’ perspectives on active surveillance for low-risk basal cell carcinoma by van Egmond, S., de Vere Hunt, I., Cai, Z., Rizk, N., Wakkee, M., Chren, M., Goldfarb, N., Simard, J., Linos, E.

Get full text